Press releases

ICON finishes the second half of 2022 with an impressive line-up of awards that commend its healthcare intelligence work and status as an employer of choice.

ICON plc announced today that Mr. Brendan Brennan, CFO of ICON plc, will present at the 2022 Evercore ISI HealthCONx Conference on Wednesday, November 30, 2022.

Quarter 3 revenue of $1,942.4 million representing an increase of 3.9% on prior year adjusted revenue and 7.4% on a constant currency organic basis.

ICON plc announces that it has been selected by BARDA, part of the ASPR, in the Department of HHS, to execute an anthrax vaccine clinical trial.

ICON plc schedules second quarter 2022 earnings conference call on Wednesday, November 2, 2022.

ICON plc today (6 Sept, 2022) releases its 2021 Environmental, Social and Governance (ESG) Report.

ICON plc announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the 2022 Wells Fargo Healthcare Conference on Wednesday, September 7, 2022. The presentation will be webcast live from 10:25am EDT.

ICON plc today announced that all resolutions at the Annual General Meeting of the Company (AGM) held on July 26, 2022 (which resolutions had all been recommended by the Board) were all duly passed by shareholders.

Quarter 2 revenue of $1,935.2 million representing a year on year increase of 122.1%.

ICON establishes university scholarship programme to provide increased opportunities for underrepresented groups to study STEM-related courses.